Digitalis Ventures
Venture capital
RollingLast verified 10 Nov 2026
Digitalis Ventures is a venture capital firm investing in biotechnology, health technologies, and animal health solutions addressing unmet medical and healthcare needs.
1 deal in the last 24 months, latest 5 Nov 2026. Derived from its deals in the news.
Key facts
- Stages
- Series B
- Sectors
- Biotech & pharma, Healthtech
- Eligible countries
- Not stated
- Timing
- Rolling applications
- Focus
- biotechnology; biomedicine and human health; animal health
- How to apply
- Apply route unknown
Recent deals
| Company | Round | Sectors | Amount | Role | Announced |
|---|---|---|---|---|---|
| T-Therapeutics | Series B | Biotech & pharma, Healthtech | €118.5M | participant | 5 Nov 2026 |
Evidence
Short excerpts from the sources, in their original language, that back the facts above.
- Kind
Through our Companion Funds, we invest in companies leveraging science, technology, and design to improve animal health.
https://www.digitalisventures.com/ - Sectors
We invest in biotechnology companies leveraging breakthrough science to improve human health, and in companies building novel technology-enabled solutions to…
https://www.digitalisventures.com/
Status history
- 6 Nov 2026: Rolling (first extraction)
Is something out of date?
Suggest an editTakes 10 seconds
Something else wrong? Report an error.
Work at Digitalis Ventures? Claim this profile to confirm what you invest in.